🇺🇸 FDA
Patent

US 7820174

T cell receptors and related materials and methods of use

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 7820174 (T cell receptors and related materials and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/56, A61K38/00